The investigational chemotherapeutic agent eribulin mesylate demonstrated activity in a heavily pretreated population of women with locally advanced or metastatic breast cancer.
Ads by Google
An anesthetic injection into a collection of nerves in the neck of breast cancer survivors may reduce the severity and frequency of debilitating hot flashes and night awakenings associated with breast cancer treatment.
The combination of mammogram and ultrasound testing can find more breast cancers.
Breast cancer risk is higher in some women and lower in others. New research shows that mammography, when combined with breast ultrasound may detect more breast cancer cases in women who have higher risk of developing the disease.
When a form of cancer that begins in the milk ducts of the breast invades neighboring tissue to spread to other parts of the body, the cause lies not in the tumor cells themselves but in a group of abnormal surrounding cells that cause the walls of the duct to deteriorate like a rusty pipe.
Scientists from deCODE genetics report the discovery of two common single-letter variants on chromosome 5 of the human genome that are associated with risk of estrogen receptor-positive breast cancer.
Researchers have identified a pattern of gene activity in mice that may help to predict individual risk for breast cancer metastasis and survival in humans. A single gene, called bromodomain 4 (Brd4), regulates the expression of this pattern, also called a signature. The researchers found that one result of this Brd4 regulation is the suppression of tumor growth and metastasis in a mouse model of cancer.
A novel systems-based approach has led researchers to an important genetic marker that can help physicians know which breast cancer patients are at highest risk and will require more aggressive treatment.
Women receiving chemotherapy for breast cancer frequently report problems with memory and concentration, but two new studies suggest that chemotherapy is not the cause of these problems, and the stress of the diagnosis may be.
A trial conducted by Roche shows that Herceptin and chemotherapy drug combination successfully treats women with aggressive form of breast cancer.
"Breast cancer is not,and should not be, a death sentence for women, regardless of the color of their skin, insurance status or income," Karen Burns White, deputy associate director of the Dana-Farber/Harvard Cancer Center Initiative to Eliminate Cancer Disparities, writes in a Boston-Bay State Banner opinion piece.
A breast cancer patient's age alone should not determine whether or not she receives standard breast-conservation treatments, including a lumpectomy and radiation therapy.
Researchers are studying racial disparities related to cancer patients.
Newly developed vaccine successfully treats breast cancer in a clinical trial and shows promising results even for those suffering from a more aggressive form of the disease.
Women diagnosed with early-stage breast cancer who choose breast-conserving surgery and radiation therapy live as long as those who opt for breast removal.
Study finds socioeconomic status affects odds patients requiring a mastectomy for breast cancer treatment will learn about breast reconstruction.
Combining a breast cancer patient's clinical characteristics with a genomic profile of her tumor may provide important information for predicting an individual patient's prognosis and accurately guiding treatment options.
Choline, an essential nutrient found in foods such as eggs, is associated with a 24 percent reduced risk of breast cancer.
The best long-term therapy for breast cancer survivors might have nothing to do with doctors or self-help books, but with Dragon boat racing.
Women with early stages of breast cancer benefit from lower doses of radiation therapy as much as from internationally approved doses.
Researchers have developed a way to quickly estimate a woman's risk for invasive breast cancer.
Today on Good Morning America, Maalak Compton-Rock was speaking about triple negative breast cancer and the foundation that was begun by a group of women who were all affected by their friend who was afflicted with triple negative breast cancer.